Home Analysis of the human cytomegalovirus pp65-directed T-cell response in healthy HLA-A2-positive individuals
Article
Licensed
Unlicensed Requires Authentication

Analysis of the human cytomegalovirus pp65-directed T-cell response in healthy HLA-A2-positive individuals

  • Juliane Schalich , Oresta Vytvytska , Wolfgang Zauner , Michael B. Fischer , Michael Buschle , Gerald Aichinger and Christoph S. Klade
Published/Copyright: March 27, 2008
Biological Chemistry
From the journal Volume 389 Issue 5

Abstract

Human cytomegalovirus (HCMV) is contained by T-lymphocyte responses focused towards the major tegument protein pp65. To systematically identify T-cell epitopes, we applied the following strategy: 441 overlapping 15mer peptides spanning the entire HCMV pp65 antigen in 1-aa steps were screened in enzyme-linked immunospot (ELIspot) assays for interferon gamma (IFN-γ) secretion by peripheral blood mononuclear cells (PBMCs) from nine healthy HCMV-seropositive subjects expressing human leukocyte antigen (HLA)-A2. This analysis confirmed a number of previously known epitopes and revealed several new ones. A total of 26 epitopes were identified, including 14 HLA-A2, four HLA-B7, -B35, -B12 and -B44 restricted class I epitopes, six class II epitopes, and two epitopes of unknown restriction. Three novel HLA-A2 epitopes were confirmed using T2-cells, and one peptide for which only binding data had been published so far was verified. Two novel class II epitopes were confirmed by intracellular cytokine staining. Responses were usually oligoclonal against up to seven HLA-A2 epitopes, albeit with a few dominating epitopes. Clusters of overlapping epitopes (hot-spots) were identified. These and the newly identified T-cell epitopes may be of great value for epitope-based immunotherapeutic approaches, including peptide vaccines.


Corresponding author

Received: 2007-11-6
Accepted: 2008-2-5
Published Online: 2008-03-27
Published in Print: 2008-05-01

©2008 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Guest Editorial
  2. Novel paradigms in vaccine development: from small pox eradication to therapeutic vaccines
  3. Highlight: 3rd Semmering Conference 2007
  4. Adaptive immune responses to hepatitis C virus: from viral immunobiology to a vaccine
  5. Dendritic cell subtypes as primary targets of vaccines: the emerging role and cross-talk of pattern recognition receptors
  6. Novel strategies to identify biomarkers in tuberculosis
  7. Not to wake a sleeping giant: new insights into host-pathogen interactions identify new targets for vaccination against latent Mycobacterium tuberculosis infection
  8. Lipopolysaccharide: a tool and target in enterobacterial vaccine development
  9. The coming of age of virus-like particle vaccines
  10. Maintenance of serological memory
  11. Adjuvant activity of type I interferons
  12. Japanese encephalitis vaccines – needs, flaws and achievements
  13. Analysis of the human cytomegalovirus pp65-directed T-cell response in healthy HLA-A2-positive individuals
  14. Non-regulatory CD8+CD45RO+CD25+ T-lymphocytes may compensate for the loss of antigen-inexperienced CD8+CD45RA+ T-cells in old age
  15. Pre-clinical development of cell culture (Vero)-derived H5N1 pandemic vaccines
  16. Construction of an encapsulated ESAT-6-based anti-TB DNA vaccine and evaluation of its immunogenic properties
  17. Review
  18. RNA switches regulate initiation of translation in bacteria
  19. Protein Structure and Function
  20. Inhibition of bacterial oxidases by formamide and analogs
  21. Modeling of variant copies of subunit D1 in the structure of photosystem II from Thermosynechococcus elongatus
Downloaded on 11.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/BC.2008.065/html
Scroll to top button